Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections like Wegovy trigger weight loss by slowing stomach emptying and signaling fullness to the brain—a mechanism that also causes temporary side effects in up to 25% of patients during the first month. Managing these effects through dose timing, food choices, and medication adjustments keeps most people on track to lose 15–22% of body weight within one year. PlexusDx offers compounded semaglutide injections starting at $149/month with flexible dosing protocols tailored to your tolerance level.

Common Side Effects of Semaglutide Injections

Nausea is the most frequently reported side effect, occurring in about 25–40% of people during the first four weeks of semaglutide therapy. This typically peaks in the first 1–2 weeks and decreases as your body adjusts to the medication. Vomiting, constipation, and mild diarrhea also occur in 10–20% of patients, while dizziness and fatigue affect fewer individuals but still require acknowledgment in treatment planning.

Injection site reactions—including redness, soreness, and minor swelling—happen in less than 5% of users and usually resolve within 24 hours without intervention. Most side effects are dose-dependent, meaning they often improve when the dose is lowered temporarily or the timing of injections is adjusted to match your eating schedule. Your dose may need to go up. Your price won't—PlexusDx keeps your monthly rate flat regardless of adjustments.

Why Semaglutide Causes Nausea and Digestive Changes

Semaglutide works by activating GLP-1 receptors in the stomach and brain, which signals your body to empty food more slowly and reduces hunger hormones. This delayed gastric emptying—while excellent for appetite control—can create the sensation of fullness, bloating, and mild nausea until your digestive system adapts. The intensity of these sensations depends partly on genetic factors affecting how many GLP-1 receptors you carry and how efficiently your body responds to the medication.

Genetic variation in the GLP1R gene (like the rs6923761 variant) influences how readily your system responds to semaglutide and may predict whether you experience stronger or milder side effects. PlexusDx's Precision Peptide Genetic Test examines this and 13 other pathways to forecast your individual response and help customize your dose escalation plan, reducing unnecessary discomfort during treatment initiation.

Practical Strategies to Reduce Nausea and Manage Side Effects

Timing your injection before your smallest meal of the day and eating slowly in smaller portions reduces nausea significantly compared to injecting before large meals. Staying hydrated, avoiding fatty and greasy foods, and choosing bland, protein-rich options like chicken, fish, eggs, and Greek yogurt during the first week after injection also minimize digestive upset. Some patients find ginger tea, peppermint, or vitamin B6 supplements helpful, though you should discuss these with your healthcare provider before adding them to your routine.

If nausea persists beyond two weeks despite dietary adjustments, discussing a temporary dose pause or reduction with your PlexusDx clinical team can help. Many patients find that staying on their current dose for an extra week before escalating allows side effects to fade naturally. Antiemetic medications like ondansetron may be prescribed short-term to support comfort while your body acclimates to the medication's mechanism.

When to Adjust Your Dose and What to Expect Long-Term

Dose escalation typically follows a 0.25–0.5 mg weekly increase pattern over 16–20 weeks, allowing your tolerance to build gradually and side effects to resolve before increasing further. If you experience moderate nausea, constipation, or vomiting that affects daily function, staying at your current dose for 1–2 extra weeks often allows adaptation without stopping treatment entirely. Roughly 70–80% of patients who experience early side effects find them completely resolved by week 4–6 of consistent therapy at a stable dose.

Long-term side effect risk decreases significantly after the first two months, with most people reporting improved tolerability and sustained appetite suppression by month three. PlexusDx tracks your response through follow-up assessments and can recommend switching to oral semaglutide or alternative compounds like tirzepatide if injection-related side effects remain problematic. Your monthly cost stays fixed whether you adjust doses, change formulations, or remain on your original prescription—ensuring affordability throughout your weight loss journey.

Serious Side Effects and When to Seek Medical Help

Severe allergic reactions to semaglutide are rare (less than 1% of users) but present as swelling of the face or throat, difficulty breathing, or severe rash within minutes to hours of injection. Pancreatitis—inflammation of the pancreas causing severe upper abdominal pain, nausea, and vomiting—occurs in fewer than 0.1% of semaglutide users but requires emergency care if suspected. Gallbladder issues and rapid dehydration from persistent vomiting also warrant immediate medical evaluation rather than home management.

Thyroid concerns have been reported rarely in patients with prior thyroid disease, and GLP-1 medications carry a boxed warning for medullary thyroid carcinoma risk in animal studies—though no human cases have been documented. Anyone with a personal or family history of thyroid cancer should discuss this with their healthcare provider before starting semaglutide. PlexusDx's clinical team reviews your complete medical history during intake to identify contraindications and ensure semaglutide is appropriate for your health profile.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long does nausea last when starting semaglutide?

Nausea typically peaks during the first 1–2 weeks and resolves within 4–6 weeks as your body adapts. If it persists beyond two weeks, adjusting meal timing, portion size, or temporarily pausing dose escalation usually resolves discomfort. PlexusDx's clinical team helps you manage this transition through personalized guidance.

Does genetic testing predict which side effects I'll experience?

PlexusDx's Precision Peptide Genetic Test analyzes 14 pathways including GLP1R rs6923761 and MC4R rs17782313 to forecast your medication response and typical side effect patterns. While genetics don't determine every symptom, they help identify patients likely to experience stronger reactions, allowing for slower dose escalation or alternative compound selection upfront.

What makes PlexusDx semaglutide different from brand-name Wegovy?

PlexusDx compounds semaglutide through licensed 503A pharmacies, offering the same active ingredient at lower cost ($149/month starting price) without insurance requirements. Your dose may need to go up. Your price won't—PlexusDx maintains flat monthly pricing across all dose adjustments, making treatment accessible and predictable.

Can I switch from semaglutide to tirzepatide if side effects don't improve?

Yes. Some patients tolerate tirzepatide better than semaglutide due to its dual GIP and GLP-1 mechanism. PlexusDx offers compounded tirzepatide injections starting at $249/month or dual-compound GLP-Squared injections if you want to combine both peptides. Your clinical team will help assess whether switching improves tolerability.

Is constipation from semaglutide dangerous, and how do I treat it?

Mild constipation affects 10–20% of patients and is rarely dangerous but uncomfortable. Increasing water intake, fiber from vegetables, and over-the-counter stool softeners usually resolve it. If severe constipation persists for more than three days or causes abdominal pain, contact your healthcare provider. PlexusDx can discuss dose adjustments or recommend oral semaglutide if injection-related constipation becomes problematic.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves